In the mission to further refine a pharmaceutical’s path to market: Risk conduct, compliance and cost balancing are three key pillars to be optimised in any temperature controlled logistics strategy.
Damage from disruptions in the supply chain can’t be completely eradicated, however they can be mitigated. Disruptions could occur in the form of natural disasters, equipment/vehicle failure or unforeseen transport delays. Companies which apply –what if – scenarios are noted to be much better equipped and agile towards facing unforeseen occurrences in the supply chain. A wrong decision made within the temperature controlled transit of a pharmaceutical, may not only be costly in a financial sense but it also in terms of physical harm caused to patients in extreme cases.